Marx, N., Deanfield, J. E., Mulvagh, S. L., Inzucchi, S. E., Pop-Busui, R., Mann, J., . . . Buse, J. B. (2026). 26-A-13845-ACC EFFECT OF ORAL SEMAGLUTIDE VERSUS PLACEBO ON FIRST AND TOTAL MACE IN SOUL TRIAL PARTICIPANTS WITH T2D AND ASCVD AND/OR CKD. Journal of the American College of Cardiology (JACC), 87(13), A198. https://doi.org/10.1016/j.jacc.2026.02.490
Chicago Style (17th ed.) CitationMarx, Nikolaus, et al. "26-A-13845-ACC EFFECT OF ORAL SEMAGLUTIDE VERSUS PLACEBO ON FIRST AND TOTAL MACE IN SOUL TRIAL PARTICIPANTS WITH T2D AND ASCVD AND/OR CKD." Journal of the American College of Cardiology (JACC) 87, no. 13 (2026): A198. https://doi.org/10.1016/j.jacc.2026.02.490.
MLA (9th ed.) CitationMarx, Nikolaus, et al. "26-A-13845-ACC EFFECT OF ORAL SEMAGLUTIDE VERSUS PLACEBO ON FIRST AND TOTAL MACE IN SOUL TRIAL PARTICIPANTS WITH T2D AND ASCVD AND/OR CKD." Journal of the American College of Cardiology (JACC), vol. 87, no. 13, 2026, p. A198, https://doi.org/10.1016/j.jacc.2026.02.490.